The United States will likely move to resume Johnson & Johnson’s COVID-19 vaccine this coming week, possibly with restrictions or broader warnings after reports of some very rare blood clot cases, the government’s top infectious diseases expert said Sunday.
Dr. Anthony Fauci, in a series of news show interviews, said he expects a decision when advisers to the Centers for Disease Control and Prevention meet Friday to discuss the pause in J&J’s single-dose vaccine
“I would be very surprised if we don’t have a resumption in some form by Friday,” he said. “I don’t really anticipate that they’re going to want it stretch it out a bit longer.”
It’s important to keep in mind that the logistical advantages of a single-dose vaccine become more important as you move down the SES ladder (Not everybody has a six-figure salary job that doesn’t actually require you to ever show up at work, like some people I could name).
Meanwhile, as of today or tomorrow, half of all adults in the US will be at least partially vaccinated, with vaccines that are apparently 100% effective in preventing death or hospitalization from COVID-19, and close to 100% effective in preventing transmission between vaccinated and unvaccinated persons.
This is an almost literally incredible scientific and technological achievement. Last year at this time the odds on achieving this would have been considered astronomically low.
Feel free to use this thread to discuss your own journey toward vaccination, if you’re so inclined. Kicking things off:
Received second Pfizer dose 10 days ago. Side effects from either dose: None, except for a sore shoulder after the first injection.